Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 104
Filter
1.
Cattle Practice ; 29(1):12-12, 2021.
Article in English | CAB Abstracts | ID: covidwho-2033861

ABSTRACT

The aims of this study are to determine if CAM use has potential to reduce unnecessary antibiotic use and support the global efforts against antimicrobial resistance, and to ensure that antimicrobials and other conventional treatment approaches are used where appropriate. 20 farms with a range of management systems, herd sizes and production goals were recruited to this study. Interviews were conducted with 24 farmers through a mixture of face-to-face, telephone and videoconferencing modalities necessitated by movement restrictions during the Covid-19 pandemic. In addition, 16 farms were visited to collect ethnographic participant observational data using ethnographic fieldnotes and photographs. Interviews were conducted using a topic guide and explored participants' experience of CAM, including drivers/barriers to CAM use, experiences of CAM use and how CAM might influence the use of conventional medicine such as antibiotics. Early findings indicate several drivers for UK dairy farmers to use CAM approaches, including their own personal [or friends' and relations'] experiences, the views of influential people and advisors, networks within the farming community and the fact that CAM use allows a greater sense of autonomy in health-based decision making. Farmers often refer to milk buyers and organic guidelines as factors which influence their use of CAM. They further refer to a desire to 'do something' for the animal and to minimise animal welfare related concerns. A range of CAM information sources were also consulted by farmers including, holistic health management organisations/courses, online materials, and pharmacies. Participating farmers associate the use of CAM approaches with other holistic health management practices, human-animal interactions, the actual character and physical characteristics of an animal and animal welfare. This indicates that CAM use is seen by farmers as part of a wider ethos and belief about holistic farming practices and land use. Additionally, data implies that some farmers value their positive personal experiences of CAM use over scientific evidence. In contrast, barriers to CAM use were also identified including: the perception that CAM approaches are reserved specifically for organic systems, little access to CAM and related resources and some existing tensions between farmers and other stakeholders' views. Early findings suggest that farmers are influenced in their use of CAM by a range of individuals within the agriculture community, including veterinary surgeons (some of whom use homeopathic practices), mainstream farming press and pro-CAM organisations and advisors.

2.
Medicinal Plant ; 13(1):84-94, 2022.
Article in English | CAB Abstracts | ID: covidwho-2026016

ABSTRACT

Post-traumatic stress disorder(PTSD) is a kind of mental disorder caused by severe traumatic events. It has a high incidence, a serious of impacts on the physical and mental health of patients. Especially in the current situation of COVID-19, the researches on PTSD are particularly important, but the choice of drugs available for PTSD is limited and it is often accompanied by adverse reactions. In the field of acupuncture, there are many clinical research evidences suggested that PTSD is a predominant disease of acupuncture. However, its action mechanisms have not been fully elucidated, so the possible mechanisms of acupuncture in treating PTSD were discussed.

3.
Zhongguo Bingdubing Zazhi = Chinese Journal of Viral Diseases ; - (3):237, 2022.
Article in English | ProQuest Central | ID: covidwho-2025830

ABSTRACT

The COVID-19 pandemic poses a huge challenge to the global economy and healthcare.Coagulation dysfunction and thrombosis are the main clinical features of severe COVID-19 patients, and closely related to the risk of death.Several mechanisms of thrombosis in COVID-19 have been proposed, such as immune inflammation, hypoxia, imbalance of angiotensin system, endothelial injury etc, and other high-risk factors such as combined with basic diseases, bed rest braking and intravenous catheterization.In this review, we summarize the mechanisms that may increase the risk of thrombosis in patients with severe COVID-19, in order to improve people′s understanding of coagulation abnormalities and thrombosis complications in patients with severe COVID-19, and further explore effective methods to prevent and treat COVID-19 related thrombosis.

4.
Zhongguo Bingdubing Zazhi = Chinese Journal of Viral Diseases ; - (3):161, 2022.
Article in English | ProQuest Central | ID: covidwho-2025829

ABSTRACT

In order to further improve the diagnosis and treatment of the new coronavirus pneumonia (COVID-19), we organized experts to revise the relevant content of the "New Coronary Virus Pneumonia Diagnosis and Treatment Plan (Trial Version 8 Revised Edition)" to form the "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version Eighth Edition)" Diagnosis and Treatment Plan for Viral Pneumonia (Trial Version 9). 1. Etiological characteristics The novel coronavirus (SARS-CoV-2) belongs to the β-genus coronavirus, with an envelope, round or oval particles, and a diameter of 60-140 nm. Has 5 essential genes for nucleoprotein (N), viral envelope (E), ... (ProQuest: Text stops here in original.)

5.
Evidence - Based Complementary and Alternative Medicine ; 2022, 2022.
Article in English | ProQuest Central | ID: covidwho-2020470

ABSTRACT

Bufei decoction (BFD) has been applied to treat chronic obstructive pulmonary disease (COPD) for centuries as a recognized traditional Chinese herbal formula. However, mechanisms of BFD on COPD are unclear. This study conducts an inquiry into the underlying mechanisms of the therapeutic effect of BFD on COPD. A COPD rat model with qi deficiency in lungs was established through induction using cigarette and sawdust smoking combined with intratracheal instillation of lipopolysaccharide following BFD treatment for 28 days. Changes in Th17/Treg cells of COPD rats with the syndrome of lung qi deficiency after BFD administration were verified using pulmonary function, ELISA, flow cytometry, histopathology, and Western blotting assays. The findings showed that BFD protected COPD rats from decreased lung function and lung injury. BFD administration reduced proinflammatory cytokines IL-6 and IL-17 secretion, promoted inhibitory cytokines IL-10 and TGF-β secretion, decreased Th17/Treg cell ratio, markedly downregulated the Th17 cell transcription factor ROR-γt expression, and upregulated transcription factor Foxp3 expression in Treg cells. We speculate that lung tonic soup improved pulmonary qi deficiency in rats with COPD by regulating the balance of Th17/Treg cells.

6.
Infection and Drug Resistance ; 15:5023-5034, 2022.
Article in English | EMBASE | ID: covidwho-2009774

ABSTRACT

Background: Since the beginning of the pandemic, scientists and researchers are highly engaged in the discovery and production of vaccines and specific treatments for COVID-19. In China, the National Health Commission has declared the use of herbal medicine combined with Western medicine as a treatment for COVID-19 and has issued many guidelines on herbal medicine-related therapies. Ethiopians have a variety of medicinal herbs to treat various viral diseases. Hence, this study aimed to assess the perception of the respondent towards COVID-19 related symptoms and traditional medicine practice for their management. Methods: A hospital-based cross-sectional study was done among 423 patients and patient attendants at the University of Gondar Comprehensive Specialized Hospital from August 6 to 27, 2021. Data were collected using a structured questionnaire, and the data were entered into Epi Info 7 and then analyzed with SPSS 20. The association between the independent and dependent variables was explained using chi-square test. Results: A total of 423 respondents participated in the study;414 (97.9%) participants heard about COVID-19 and responded correctly to the chief clinical symptoms. Fever is the most perceived symptom, reported by 378 (91.3) respondents, and the least reported symptom was loss of taste and smell by 30 (7.2%) respondents. This study showed that home remedies were practiced by 323 of the total respondents, and herbal medicines were the second most and practiced by 316 respondents. Monthly income and perceived knowledge about chief symptoms were statistically significantly associated (p < 0.05) with the use of complementary and alternative medicine for the management of COVID-19 related symptoms. Conclusion: This study found that most of the respondents have knowledge about the signs and symptoms of COVID-19 and the traditional medicine is being practiced by most of the study participants as a management for COVID-19 and related symptoms.

7.
Journal of Clinical Oncology ; 40(16), 2022.
Article in English | EMBASE | ID: covidwho-2009573

ABSTRACT

Background: Estrogen receptor positive breast cancer (BC) is the most common type of breast cancer in postmenopausal women and aromatase inhibitors (AI) are the endocrine therapy of choice recommended for these patients. Up to 50% of those treated with an AI develop Arthralgia often resulting in poor adherence and decreased quality of life. Methods: This is a single arm longitudinal pilot study aiming to evaluate the safety, feasibility, acceptability and potential efficacy of TaiChi4Joint, a remotelydelivered 12-week Tai Chi intervention designed for the relief of AI-induced joint pain. Women diagnosed with stage 0-III BC who have been receiving an AI for at least 2 months and reporting arthralgia with a ≥ 4 score on a 0-10 scale for joint pain were eligible for study enrollment. Participants were encouraged to join Tai Chi classes delivered over ZOOM three times a week for 12 weeks. Program engagement strategies include the use of a private Facebook study group and box.com cloud for archiving live class recordings. The program utilizes Text messaging and emails with periodic positive quotes and evidence based information on Tai Chi for facilitating community bonding and class attendance. Participants were invited to complete the following assessments online at baseline, 1, 2 and 3 months intervals from study enrollment: Brief Pain Inventory (BPI), Western Ontario and McMaster University Osteoarthritis index (WOMAC), The Australian Canadian Osteoarthritis Hand Index (AUSCAN), Fatigue Symptom Inventory (FSI), Hot Flash Related Daily Interference Scale (HFRDIS), Pittsburg Sleep Quality Index (PSQI) and Center for Epidemiological Studies Depression (CES-D). Results: 55 eligible patients were invited to participate and 39 consented and completed the baseline assessments. 61% (median) Participants attended the classes, with no Tai Chi related adverse events reported. 22 of the 39 participants completed the 3-month follow up assessments with a 56% retention rate. Study participants reported improvement from baseline compared to 3 month as follows: For BPI (P = .000), AUSCAN pain subscale (P =.000), AUSCAN function subscale for 35 patients (P = .000), WOMAC (P = .000), CES-D (P = 0.001), FSI (P = 0.00) and PSQI (P = .000). However HFRDIS improved in 11 patients (P = 0.00) for the other 22 patients (P = 0.154). Conclusions: The COVID-19 global pandemic has resulted in the need to rethink how mind-body therapies can be delivered. This study demonstrated the feasibility, acceptability, and potential efficacy of a Telehealth based Tai Chi intervention for reducing AI-induced arthralgia. The intervention decreased patient reported pain, stiffness and improved sleep quality and depressive symptoms. With our promising findings, larger telehealth based trials of Tai Chi for AI-associated arthralgia are needed.

8.
Medical Acupuncture ; 33(4):260-261, 2021.
Article in English | EMBASE | ID: covidwho-1577539

ABSTRACT

Physical and mental health challenges seem to be part of our daily living. To understand the latest consensus, I attended a symposium, June 30, 2021, advocating global health by using acupuncture and integrative medicine at the Lansdowne Resort for a Global Wellness Event, in Leesburg, Virginia. Group sound bathing and meditation were offered to the participants in a therapeutic session. This was to prepare our minds and bodies for the experience of this symposium. Do we wish to lead a revolution in the science of health—especially now—to maintain and thrive in the era of COVID-19? This was the main theme of this event. To understand COVID-19 better, experts were present who explained its biology and perhaps what might be expected in the future as this virus winds down or rebounds as variants.

9.
Integrative Medicine Research ; 11(4), 2022.
Article in English | EMBASE | ID: covidwho-2007767
10.
Canadian Veterinary Journal ; 63(3):233-234, 2022.
Article in English | EMBASE | ID: covidwho-2006854
11.
Journal of Clinical Oncology ; 40(16), 2022.
Article in English | EMBASE | ID: covidwho-2005722

ABSTRACT

Background: Complementary and alternative medicine (CAM) use has been associated with worse survival outcomes in cancer patients compared to standard of care therapies. CAM has received a significant increase in public awareness and interest in the COVID-19 pandemic era. We sought to understand how the COVID-19 pandemic affected CAM use and perceptions in cancer patients. Methods: Data was collected from adult cancer patients prospectively enrolled on a cross-sectional survey conducted at an NCI-designated cancer center and a comprehensive cancer center between 2020 and 2021. The survey included questions assessing changes in patient attitude towards CAM and likelihood of using CAM, both relative to prior to COVID-19. Analyzed CAM users included those taking vitamin, mineral and herbal supplements, alternative medicines and special diets, and excluded mindbody practices as the focus of this analysis was on enteral and parenteral CAM therapies. Differences in the impact of COVID-19 on CAM use beliefs and practices between CAM users and non-users were analyzed with χ2 and two-sample t-tests. Results: Out of 749 respondents, 578 (77%) used any CAM and 470 (63%) used enteral or parenteral CAM. Results shown in table. Compared to prior to COVID- 19, CAM users were more likely to view CAM more favorably (12% vs 5%, p < 0.01), while non-users were more likely to have an unchanged opinion (90% vs 84%, p = 0.03). Females had higher rates of viewing CAM more favorably than males (80% vs 58%, p = 0.04). Patients who viewed CAM more favorably had higher rates of self-reported incurable cancer (36% vs 11%, p = 0.04), declining recommended hormone therapy (22% vs 0%, p < 0.01), and higher trust of social media (19% vs 0%, p = 0.02) and websites (24% vs 0%, p < 0.01). Since the start of COVID-19, CAM users were more likely to report increased likelihood of using CAM (12% vs 6%, p = 0.01). Patients who were more likely to use CAM had higher rates of declining recommended chemotherapy (12% vs 0%, p = 0.02), and higher trust of social media (15% vs 2%, p = 0.01) and websites (28% vs 7%, p < 0.01). Conclusions: During the COVID-19 pandemic, attitudes on CAM use in oncology patients have become increasingly polarizing. Patients with favorable attitudes toward CAM were likely to decline recommended standard of care therapy and more like to use CAM since COVID-19. This data helps characterize shifting attitudes toward CAM and may help guide shared decision-making between physician and patient.

12.
Evidence - Based Complementary and Alternative Medicine ; 2022, 2022.
Article in English | ProQuest Central | ID: covidwho-2001955

ABSTRACT

Global and antigen-independent immunosuppression by growing tumours can cause life-threating damage when concurrent with an infection in tumour-bearing hosts. In the present study, we investigated whether the oral administration of the Japanese traditional herbal (Kampo) medicine, juzentaihoto (JTT), plays a role in the improvement of antiviral cellular immunity in tumour-bearing hosts. Female BALB/c mice subcutaneously injected with murine colorectal cancer CT26 cells fed a control or JTT diet were inoculated with recombinant vaccinia virus expressing human immunodeficiency virus-1 glycoprotein 160 (vSC25). At 7 days postinfection, anti-vSC25 cellular immunity was evaluated by measuring the abundance of splenic virus-specific CD8+ T cells. JTT had no impact on CT26 tumour growth in vivo. Surprisingly, JTT augmented anti-vSC25 cellular immunity in CT26-bearing mice. Depletion of either CD25+ regulatory T (Treg) cells or myeloid-derived suppressor cells (MDSCs) also enhanced anti-vSC25 cellular immunity in tumour-bearing mice but had no therapeutic benefit against tumour growth. However, JTT had no impact on the abundance of these immunosuppressive cells. Overall, our data indicates that JTT contributes to the improvement of anti-vSC25 cellular immunity in tumour-bearing hosts possibly via a mechanism independent of CD25+ Treg cells and MDSCs, suggesting that this Kampo medicine can act as a promising antiviral adjuvant in an immunosuppressive state caused by tumours.

13.
Evidence - Based Complementary and Alternative Medicine ; 2022, 2022.
Article in English | ProQuest Central | ID: covidwho-2001940

ABSTRACT

Type 2 diabetes mellitus (T2DM) is a severe disease caused by metabolic disorders, particularly carbohydrate metabolism disorders. The disease is a fatal global trouble characterised by high prevalence rates, causing death, blindness, kidney failure, myocardial infarction, amputation of lower limps, and stroke. Biochemical metabolic pathways like glycolysis, gluconeogenesis, glycogenesis, and glycogenolysis are critical pathways that regulate blood glucose levels with the glucokinase (GK) enzyme playing a central role in glucose homeostasis. Any factor that perturbs the aforementioned biochemical pathways is detrimental. Endocrinological, neurophysiological, and molecular biological pathways that are linked to carbohydrate metabolism should be studied, grasped, and manipulated in order to alleviate T2DM global chaos. The challenge, howbeit, is that, since the body is an integration of systems that complement one another, studying one “isolated” system is not very useful. This paper serves to discuss endocrinology, neurophysiology, and molecular biology pathways that are involved in carbohydrate metabolism in relation to T2DM.

14.
Evidence - Based Complementary and Alternative Medicine ; 2022, 2022.
Article in English | ProQuest Central | ID: covidwho-2001936

ABSTRACT

Background. The application of virtual reality (VR) in clinical settings is growing rapidly, with encouraging results. As VR has been introduced into complementary and alternative medicine (CAM), a systematic review must be undertaken to understand its current status. Aim. This review aims to evaluate and summarize the current applications of VR in CAM, as well as to explore potential directions for future research and development. Methods. After a brief description of VR technology, we discuss the past 20 years of clinical VR applications in the medical field. Then, we discuss the theoretical basis of the combination of VR technology and CAM, the research thus far, and practical factors regarding usability, etc., from the following three main aspects: clinical application, teaching, and scientific research. Finally, we summarize and propose hypotheses on the application of VR in CAM and its limitations. Results. Our review of the theoretical underpinnings and research findings to date leads to the prediction that VR and CAM will have a significant impact on future research and practice. Conclusion. Although there is still much research needed to advance the science in this area, we strongly believe that VR applications will become indispensable tools in the toolbox of CAM researchers and practitioners and will only grow in relevance and popularity in the era of digital health.

15.
Advances in Predictive, Preventive and Personalised Medicine ; 12:xiii-xvi, 2020.
Article in English | Scopus | ID: covidwho-1989216

ABSTRACT

Introducing Information Technology (IT) tools in today’s and future medicine is being increasingly considered all over the world, especially in developed countries. Indeed, these countries are suffering the most from population aging and chronic diseases. This induces original challenges not only for healthcare but also for wellbeing. In this sense, Predictive, Preventive and Personalised Medicine (3PM) has been identified since more than a decade as a research avenue having huge potential for developed societies. © Springer Nature Switzerland AG 2020.

16.
Medicine and Pharmacy Reports ; 95(3):236-242, 2022.
Article in English | EMBASE | ID: covidwho-1979751

ABSTRACT

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global public health concern and is characterized by an exaggerated inflammatory response that can lead to a large variety of clinical manifestations such as respiratory distress, sepsis, coagulopathy, and death. While it was initially considered primarily a respiratory illness, different data suggests that COVID-19 can lead to a pro-inflammatory milieu and a hypercoagulable state. Several mechanisms attempt to explain the pro-coagulant state seen in COVID-19 patients, including increased fibrinogen concentration, different receptor binding, exhausted fibrinolysis, cytokine storm, and endothelial dysfunction. Some hematological parameters, such as elevated D-dimers and other fibrinolytic products, indicate that the essence of coagulopathy is massive fibrin formation. Moreover, elevated D-dimer levels have emerged as an independent risk factor for a worse outcome, including death, indicating a potential risk for deep vein thrombosis and pulmonary thromboembolism. Prophylactic anticoagulation is recommended in all inpatients with COVID-19 to reduce the incidence of thrombosis. Those with elevated D-dimer values or with a higher risk of developing thromboembolic events should be treated with higher doses of anticoagulant. Anticoagulation may not be enough in some circumstances, highlighting the need for alternative therapies. An understanding of the complex cross-talk between inflammation and coagulopathy is necessary for developing direct appropriate interventional strategies.

17.
Journal of Clinical and Experimental Hepatology ; 12:S45, 2022.
Article in English | EMBASE | ID: covidwho-1977436

ABSTRACT

Background and Aims: ACLF is a condition in which 2 insults to liver operate simultaneously, 1 being chronic, and other acute. Complementary & alternative medicine (CAM) are important causes for ACLF. India is the birth place of Ayurveda & CAM is considered safe by the common population with around 80% of the population relying on it. CAM consumption has increased in recent years. Due to the pandemic and the focus on improved immunity, the consumption of CAM has gone up. India has reported 4.8 lakh COVID 19 related deaths till December 2021. However, WHO has estimated 4.7 million deaths directly or indirectly related to COVID-19. We documented a case series of CAM related DILI-ACLF, with CAM being consumed for COVID prevention Methods: ACLF established with APASL defining criteria. USG was done to assess for features of CLD. Liver biopsy was done where feasible. Results: Case 1-39-year-old diabetic taking Giloy Kwath for 2 months for COVID prevention. Presenting with jaundice & ascites having MELD score 18 and CTP class B, he had NASH related cirrhosis on biopsy and is still on follow up. Case 2- f/u/c of CTP A alcoholic cirrhosis who consumed a crushed herb for protection against COVID given by a quack for 3 months, with no alcohol intake in 2 years. He presented with jaundice and encephelopathy, had MELD score 38 & CTP C & succumbed to illness. Case 3 49-year-old lady consuming Giloy Kwath for 4 months for COVID prevention. She was diagnosed with AIH type 1 with MELD score 39. She succumbed to illness with post-mortem liver biopsy showed features of AIH cirrhosis Conclusion: CAM is the most common cause of drug induced ACLF. CAM consumption increased during the pandemic and may have lead to increase in indirect COVID related deaths

18.
Gaceta Sanitaria ; 35(Suppl. 2):S103-S618, 2021.
Article in English | GIM | ID: covidwho-1970112

ABSTRACT

This conference proceeding contains 126 articles that discuss a variety of topic which includes public health, COVID-19, health and agriculture, maternal and child health, aromatherapy, mental health, health care and health services, traditional medicine, culture, maternal and child health, food safety, media communications, reproductive and sexual health, water quality and safety, socioeconomics and nutrition, among others.

19.
Indian Journal of Psychiatry ; 64(4):401-407, 2022.
Article in English | EMBASE | ID: covidwho-1957515

ABSTRACT

Background: The Indian population is suffering from a high prevalence of mental stress and the situation has been worsened by the COVID-19 pandemic. Mindfulness, which can also be conducted online, has been used as a stress-relieving therapy in the Western world. There is not much experience with mindfulness in the Indian population. The COVID-19 pandemic demands the development of alternative therapies which can reach out to the masses at a minimal cost, avoiding direct personal contact. The researchers wanted to explore the potential of mindfulness as a stress-relieving therapy. Aim: To note any improvement in perceived stress of the participants compared to the controls. Methods: Ninety apparently healthy adults were randomized into group M (all of whom participated in an online mindfulness program) and group C (all of whom attended placebo sessions), with 45 participants each. Final sample size was n = 42 (group M) and n = 38 (group C). The perceived stress was measured using the perceived stress scale before and after the program. Qualitative data was collected in the form of written responses to the question 'Which aspect of mindfulness meditation appealed to you the most for stress relief?' and some themes were formed. Results: There was a significant decrease in perceived stress scale scores on completion of the program in group M. 'Positive mental state' and 'non-judgmental' were the most prominent emergent themes suggested by the participants, as per the qualitative data analysis. Conclusion: This preliminary study sees potential in an online mindfulness program as an alternative stress-relieving therapy. Further research is suggested to substantiate the results and optimize the implementation.

20.
American Journal of Respiratory and Critical Care Medicine ; 205(1), 2022.
Article in English | EMBASE | ID: covidwho-1927841

ABSTRACT

Background: Currently, there is no effective treatment available for COVID-19 infection. FDAauthorized drugs' emergency uses are still not widely available and not affordable to most patients in developing countries. Therefore, here we look for an affordable alternative therapy, Eucalyptus oil, which is already being used as a household remedy for respiratory infections in Indonesia. This study aimed to find out the role of Eucalyptus oil as adjunctive in coronavirus disease 2019.Methods: 50 mild-moderate COVID-19 patients were randomly assigned for a prospective clinical trial conducted in one of the academic hospitals in the eastern part of Indonesia. A group of 24 patients was given standard COVID-19 treatment as a control group, while another 26 patients were given standard therapy plus Eucalyptus oil as an adjuvant. Patients were followed for 15 days. The clinical symptoms, negative results of RT-PCR, and viral load were recorded during the study period. Clinical outcome symptoms parameter consisted of anosmia and cough. A negative result of COVID-19 was analyzed through qualitative real-time polymerase chain reaction (RT-PCR). Viral load analysis was undertaken by measuring the cycle threshold (Ct) values as indirect representatives. Results: There was a better trend of improvement of clinical symptoms among patients who received adjuvant treatment than the control group. Anosmia and cough were recovered faster in the treatment group. Negative proportion of COVID-19 RT-PCR is higher in treatment group than in control group (on day-10: 53.85% vs 20.83%, p = 0.0163;on day-15: 76.92% vs 54.16%, p = 0.0897), showing a faster conversion when administered with Eucalyptus oil. Cycle threshold (Ct) values of the treatment population are significantly higher on day-10 (representing the decrease of viral load) compared to those who received standard therapy only (p = 0.007). Conclusions: Using Eucalyptus oil as adjuvant of COVID-19 treatment promotes better recovery of clinical symptoms (anosmia and cough), faster conversion to negative RT-PCR result, and decreased viral load of mild-moderate COVID-19 patients.

SELECTION OF CITATIONS
SEARCH DETAIL